Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants
Tonino Alonzi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Delia Goletti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Massimo Francalancia(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Emanuele Nicastri(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Mauro Piacentini(University of Rome Tor Vergata), Giovanni Delogu(Università Cattolica del Sacro Cuore), Laura Falasca(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Federica Repele(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Anna Rosa Garbuglia(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Alessandra Aiello(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani)
Cited by 17
Related Papers
Molecular definitions of autophagy and related processes
|The EMBO Journal|2017|1.6k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|715
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
|Nature|2001|464
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
|Journal of Infection|2020|445